Lauren Eillen Macaraeg, MD
Internal Medicine · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 3 carriers
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · West Coast Kidney · 56 clinicians in this group
Hospitals listed: 052719 · 552811 · Ahmc Seton Medical Center · California Pacific Medical Center - Mission Bernal · Mills-Peninsula Medical Center · UCSF Health Stanyan Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
19 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Macaraeg’s office at (650) 755-4490 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A164350 · Current
Licensed to practise in California · since 2019 · expires 2027-08-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Peninsula dialysis access centerAmbulatory Surgery Center · South San Francisco, CA6% owner since 2024 · accredited by HFAPInitial Accreditation1 inspection, 1 with deficiencies · last 2025-07-29
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Checkups this office reported
14 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 67.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 8%That's few of the people this applied to. | 209 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 58%That's more than half. | 65 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 39 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 0%That's few of the people this applied to. | 30 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 170 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 15% | 20 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 246 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 0%That's few of the people this applied to. | 37 |
See the other 6 measures
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 95%That's most of the people this applied to. Worse on this measure. | 37 |
| Medications listed in the chartVisits where the current medication list was documented | 37%That's less than half. | 1,086 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 176 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 18% | 379 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 89%That's most of the people this applied to. | 64 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 24%That's few of the people this applied to. | 221 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$251,345
Medicare paid this office $251,345 for 404 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 27 | $40,575 | $310 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 131 | $33,899 | $68 |
| Critical care, first 30-74 minutes | 67 | $31,338 | $181 |
| Return visit (30+ min) | 104 | $31,083 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 136 | $30,419 | $103 |
See all 16 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 27 | $40,575 | $310 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 131 | $33,899 | $68 |
| Critical care, first 30-74 minutes | 67 | $31,338 | $181 |
| Return visit (30+ min) | 104 | $31,083 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 136 | $30,419 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $19,105 | $147 |
| Long return visit (40+ min) | 40 | $12,189 | $165 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $10,642 | $266 |
| Hemodialysis procedure with physician evaluation | 82 | $10,449 | $61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 112 | $4,798 | $15 |
| Transitional care management services for problem of at least moderate complexity | 22 | $4,632 | $201 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $4,097 | $186 |
| New patient visit (60+ min) | 20 | $3,837 | $192 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,646 | $115 |
| New patient visit (45+ min) | 18 | $2,633 | $146 |
| Advance care planning, first 30 minutes | 13 | $1,012 | $67 |
Who their Medicare patients are
404 Original Medicare patients in 2024. Average age 76 · Under 65 14% · 85 and older 24% · Women 45% · Also on Medicaid 46% · Health risk score 5.08. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 69% · Heart failure 63% · Coronary heart disease 50% · Atrial fibrillation 45% · Depression 29% · Dementia 26% · Stroke 25% · COPD 21% · Cancer 18%.
The office billed $689,403, Medicare allowed $322,258 and paid $251,345; for 2,340 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 404 | 2,340 | 76 | 5.08 | $689,403 | $251,345 |
| 2023 | 360 | 1,546 | 76 | 5.22 | $564,672 | $213,222 |
| 2022 | 179 | 756 | 76 | 4.21 | $231,694 | $86,318 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 39 | $51,111 | $316 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 138 | $43,302 | $104 |
| Critical care, first 30-74 minutes | 69 | $28,974 | $187 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $18,756 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 108 | $17,663 | $68 |
| Return visit (30+ min) | 63 | $17,059 | $116 |
| Long return visit (40+ min) | 38 | $10,423 | $158 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $6,889 | $265 |
| Hemodialysis procedure with physician evaluation | 64 | $6,814 | $63 |
| New patient visit (60+ min) | 22 | $4,156 | $189 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,530 | $110 |
| New patient visit (45+ min) | 14 | $1,920 | $137 |
2022: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $17,727 | $62 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $16,002 | $320 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $13,911 | $90 |
| Critical care, first 30-74 minutes | 27 | $12,488 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,454 | $173 |
| Hemodialysis procedure with physician evaluation | 27 | $4,405 | $64 |
| New patient visit (60+ min) | 14 | $2,648 | $189 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,359 | $118 |
| Return visit (30+ min) | 12 | $1,550 | $119 |
Medicaid work
$33,703 in 2024
Medicaid paid $33,703 for 463 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 60 | $14,520 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 148 | $7,909 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 90 | $5,940 |
| Return visit (30+ min) | 94 | $5,014 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 71 | $319 |
| 2024 | 463 | 5 | 18 | $33,703 |
| 2023 | 360 | 4 | 20 | $21,121 |
| 2022 | 15 | 1 | 15 | $2,038 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 40 | $8,575 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 267 | $8,493 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 40 | $3,528 |
| Return visit (30+ min) | 13 | $525 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 15 | $2,038 |
Drugs they prescribed that Part D paid
$214,385
Pharmacies billed $214,385 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,158) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
979 generic and 179 brand-name prescriptions · $214,385 in drug cost · 35 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 47 | $65,976 | $1,404 |
| Farxiga | 16 | $16,907 | $1,057 |
| Januvia | 13 | $12,448 | $958 |
| Sevelamer Carbonate | 20 | $6,763 | $338 |
| Prosol | 38 | $6,097 | $160 |
See all 27 drugs
| Jardiance | 47 | $65,976 | $1,404 |
| Farxiga | 16 | $16,907 | $1,057 |
| Januvia | 13 | $12,448 | $958 |
| Sevelamer Carbonate | 20 | $6,763 | $338 |
| Prosol | 38 | $6,097 | $160 |
| Bumetanide | 24 | $2,061 | $86 |
| Valsartan | 21 | $1,257 | $60 |
| Nifedipine Er | 17 | $1,057 | $62 |
| Torsemide | 20 | $1,033 | $52 |
| Tamsulosin | 46 | $911 | $20 |
| Finasteride | 56 | $900 | $16 |
| Carvedilol | 52 | $772 | $15 |
| Losartan | 79 | $628 | $8 |
| Olmesartan Medoxomil | 15 | $570 | $38 |
| Hydralazine | 29 | $547 | $19 |
| Amlodipine Besylate | 78 | $503 | $6 |
| Chlorthalidone | 37 | $477 | $13 |
| Atorvastatin | 31 | $462 | $15 |
| Furosemide | 60 | $385 | $6 |
| Calcitriol | 15 | $299 | $20 |
| Isosorbide Mononitrate Er | 11 | $203 | $18 |
| Spironolactone | 28 | $191 | $7 |
| Irbesartan | 12 | $186 | $15 |
| Hydrochlorothiazide | 11 | $166 | $15 |
| Lisinopril | 20 | $162 | $8 |
| Gabapentin | 25 | $156 | $6 |
| Clonidine | 19 | $51 | $3 |
Year by year
| 2024 | 1,158 | 239 | 0% (0) | 15% | $214,385 |
| 2023 | 704 | 172 | 0% (0) | None | $153,457 |
| 2022 | 143 | 57 | 0% (0) | None | $22,767 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Farxiga | 23 | $22,712 | $987 |
| Jardiance | 17 | $18,749 | $1,103 |
| Prosol | 58 | $7,921 | $137 |
| Sevelamer Carbonate | 12 | $4,415 | $368 |
| Clonidine | 11 | $1,951 | $177 |
| Bumetanide | 11 | $826 | $75 |
| Amlodipine Besylate | 47 | $765 | $16 |
| Nifedipine Er | 23 | $739 | $32 |
| Labetalol | 11 | $722 | $66 |
| Carvedilol | 42 | $667 | $16 |
| Torsemide | 14 | $627 | $45 |
| Chlorthalidone | 29 | $530 | $18 |
| Hydralazine | 16 | $524 | $33 |
| Losartan | 33 | $446 | $14 |
| Clonidine | 13 | $323 | $25 |
| Lisinopril | 18 | $315 | $17 |
| Lidocaine-Prilocaine | 11 | $287 | $26 |
| Tamsulosin | 13 | $259 | $20 |
| Furosemide | 28 | $236 | $8 |
| Atorvastatin | 13 | $162 | $12 |
| Spironolactone | 11 | $124 | $11 |
| Gabapentin | 12 | $66 | $6 |
2022: 2 drugs
| Amlodipine Besylate | 14 | $170 | $12 |
| Chlorthalidone | 12 | $167 | $14 |
Money from drug and device companies
$1,999 in 2025
| 2025 | 18 | 71 | None | $1,999 |
| 2024 | 15 | 48 | None | $1,168 |
| 2023 | 8 | 39 | None | $1,042 |
| 2022 | 1 | 1 | None | $122 |
| 2020 | 1 | 2 | None | $30 |
| 2019 | 1 | 4 | None | $57 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Farxiga | $268 | 11 payments
|
| Mallinckrodt Hospital Products | Acthar | $248 | 9 payments
|
| Novartis Pharmaceuticals | Fabhalta | $223 | 8 payments
|
| Novo Nordisk | Wegovy | $197 | 5 payments
|
| Calliditas Therapeutics US | Tarpeyo | $189 | 9 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $147 | 5 payments
|
See all 71 published payments
| Mallinckrodt Hospital Products | Meals · 2025-12-31 | Acthar | $32 |
| Calliditas Therapeutics US | Meals · 2025-12-15 | Tarpeyo | $14 |
| Novartis Pharmaceuticals | Meals · 2025-12-12 | Fabhalta | $33 |
| ANI Pharmaceuticals | Meals · 2025-12-11 | Purified Cortrophin Gel | $29 |
| Apellis Pharmaceuticals | Meals · 2025-12-09 | Empaveli | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-19 | Farxiga | $26 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-13 | Kerendia | $24 |
| Akebia Therapeutics | Meals · 2025-11-07 | Vafseo | $24 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Fabhalta | $25 |
| Novo Nordisk | Meals · 2025-10-29 | Wegovy | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-22 | Lokelma | $27 |
| Mallinckrodt Hospital Products | Meals · 2025-10-15 | Acthar | $34 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-10 | Jardiance | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-03 | Kerendia | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-02 | Fabhalta | $32 |
| Mallinckrodt Hospital Products | Meals · 2025-09-24 | Acthar | $29 |
| Novartis Pharmaceuticals | Meals · 2025-09-19 | Vanrafia | $25 |
| Novartis Pharmaceuticals | Meals · 2025-09-16 | Fabhalta | $26 |
| Otsuka America Pharmaceutical | Meals · 2025-09-11 | Jynarque | $17 |
| Ardelyx | Meals · 2025-08-22 | Ibsrela | $23 |
| ANI Pharmaceuticals | Meals · 2025-08-14 | Purified Cortrophin Gel | $35 |
| Mallinckrodt Hospital Products | Meals · 2025-08-09 | Acthar | $34 |
| Akebia Therapeutics | Meals · 2025-08-07 | Vafseo | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-08-05 | Jynarque | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-01 | Lokelma | $30 |
| Ardelyx | Meals · 2025-07-29 | Ibsrela | $27 |
| Mallinckrodt Hospital Products | Meals · 2025-07-18 | Acthar | $27 |
| Scpharmaceuticals | Meals · 2025-06-24 | Furoscix | $25 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-17 | Jardiance | $30 |
| Mallinckrodt Hospital Products | Meals · 2025-06-14 | Acthar | $8 |
| Mallinckrodt Hospital Products | Meals · 2025-06-14 | Acthar | $12 |
| Amgen | Meals · 2025-06-12 | Tavneos | $111 |
| Lilly USA | Meals · 2025-06-05 | Jardiance | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-05 | Lokelma | $24 |
| Ardelyx | Meals · 2025-06-05 | Ibsrela | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-06-04 | Acthar | $36 |
| Amgen | Meals · 2025-05-30 | Tavneos | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-28 | Lokelma | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-23 | Lokelma | $1 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-23 | Lokelma | $28 |
| Calliditas Therapeutics US | Meals · 2025-05-23 | Tarpeyo | $5 |
| Calliditas Therapeutics US | Meals · 2025-05-23 | Tarpeyo | $8 |
| Calliditas Therapeutics US | Meals · 2025-05-23 | Tarpeyo | $34 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-16 | Kerendia | $34 |
| Calliditas Therapeutics US | Meals · 2025-05-16 | Tarpeyo | $37 |
| Novo Nordisk | Meals · 2025-05-14 | Wegovy | $14 |
| Novo Nordisk | Meals · 2025-05-08 | Wegovy | $23 |
| Mallinckrodt Hospital Products | Meals · 2025-05-02 | Acthar | $36 |
| Ardelyx | Meals · 2025-04-29 | Ibsrela | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-04-01 | Jynarque | $26 |
| Novartis Pharmaceuticals | Meals · 2025-03-28 | Fabhalta | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-22 | Farxiga | $24 |
| Travere Therapeutics | Meals · 2025-03-18 | None | $34 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-14 | None | $27 |
| ANI Pharmaceuticals | Meals · 2025-03-13 | Purified Cortrophin Gel | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-12 | Farxiga | $29 |
| Novo Nordisk | Meals · 2025-02-25 | Ozempic | $23 |
| Novo Nordisk | Meals · 2025-02-24 | Wegovy | $122 |
| Otsuka America Pharmaceutical | Meals · 2025-02-18 | Jynarque | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-15 | Kerendia | $34 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-14 | Kerendia | $32 |
| Calliditas Therapeutics US | Meals · 2025-02-11 | Tarpeyo | $22 |
| Novartis Pharmaceuticals | Meals · 2025-02-07 | Fabhalta | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-01 | Farxiga | $35 |
| Calliditas Therapeutics US | Meals · 2025-01-28 | Tarpeyo | $2 |
| Calliditas Therapeutics US | Meals · 2025-01-28 | Tarpeyo | $32 |
| Aurinia Pharma U.S. | Meals · 2025-01-24 | Lupkynis | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-01-17 | Jynarque | $23 |
| Calliditas Therapeutics US | Meals · 2025-01-16 | Tarpeyo | $36 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-14 | Farxiga | $26 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Fabhalta | $28 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $1,168
| Amgen | Tavneos | $187 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $159 | 7 payments
|
| Calliditas Therapeutics US | Tarpeyo | $133 | 7 payments
|
| Novartis Pharmaceuticals | Fabhalta | $124 | 4 payments
|
| Mallinckrodt Hospital Products | Acthar | $108 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $102 | 4 payments
|
| Novo Nordisk | Ozempic | $98 | 5 payments
|
| Aurinia Pharma U.S. | Lupkynis | $53 | 2 payments
|
| Lilly USA | Jardiance | $51 | 2 payments
|
| Travere Therapeutics | None | $35 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Livtencity | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $24 | 1 payment
|
| Ardelyx | Ibsrela | $23 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
2023: $1,042
| Amgen | Aranesp | $234 | 4 payments
|
| Mallinckrodt Hospital Products | Acthar | $229 | 11 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $163 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $153 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $130 | 7 payments
|
| Otsuka America Pharmaceutical | Jynarque | $75 | 3 payments
|
| Calliditas Therapeutics US | Tarpeyo | $41 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
2022: $122
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $122 | 1 payment
|
2020: $30
| E.R. Squibb & Sons L.L.C. | Eliquis | $30 | 2 payments
|
2019: $57
| E.R. Squibb & Sons L.L.C. | Eliquis | $57 | 4 payments
|
Professional record
- NPI
- 1730612532
- Licence
- CA A164350California A164350: Current · expires 2027-08-31
- Group
- West Coast Kidney
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 1498 Southgate Ave # 102, Daly City, CA, 94015
- NPI first listed
- 2017-04-07
- NPI last updated
- 2022-06-27
- NPI record certified
- 2022-06-27
This is when the NPI record was last certified, not a medical board exam.